Extended Half-life Coagulation Factors for Hemophilia Therapy: Clinically Advantageous, Challenging for the Laboratory Webinar

This presentation will provide an overview of the next generation extended half-life FVIII and FIX replacement therapies and review some of the challenges clinical laboratories encounter when monitoring these treatments using standard factor activity assays commonly used in the clinical laboratory.